Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

SOLUGEN INC

Filed by SOLUGEN INC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 18, 2025
Income
Not reported
Expenses
$150,000.00
Registrant
SOLUGEN INC
Filing UUID
fbd78f0f-69a5-461d-859a-d1c6bb0cbacf
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

DEF · Defense

Support the use of bio-based chemicals in the Department of Defense, generally. (S. 4638) FY 2025 National Defense Authorization Act, educate and advocate for secure supply chains. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.

Literal federal measure citations: S. 4638

ENV · Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Monitor implementation of (P.L.117-58), Infrastructure Investment and Jobs Act. Monitor implementation of (P.L. 117-169), Inflation Reduction Act. Monitor implementation of (Executive Order: 14081) Executive Order on Advancing Biotechnology and Biomanufacturing. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-18) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.